Sorafenib EP Impurity G
Product Type
Impurity Standards
CAT. No.
MRL-S07007
CAS. No.
18585-06-3
Mol. F.
C10H9ClF3NO2
Mol. Wt.
267.63
Synonyms
NA
Chemical Name
Ethyl [4-chloro-3-(trifluoromethyl)phenyl]carbamate (as per EP)
Stock Status
Custom Synthesis
Sorafenib EP Impurity G with CAS No:18585-06-3 is an impurity standard of Sorafenib. Sorafenib is a medication used in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and radioactive iodine-resistant thyroid cancer. Chemically, it is a kinase inhibitor that targets multiple signaling pathways involved in tumor growth and angiogenesis. Sorafenib inhibits the activity of kinases such as Raf, VEGFR (vascular endothelial growth factor receptor), and PDGFR (platelet-derived growth factor receptor). By disrupting these pathways, sorafenib helps slow down cancer cell proliferation and reduce the growth of blood vessels that supply tumors. It is typically administered orally in tablet form and is considered an important therapeutic option in the management of certain advanced cancers. Buy high quality Sorafenib EP Impurity G from from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Sorafenib EP Impurity G
Request for Quotation : Sorafenib EP Impurity G
Related Products
Sorafenib EP Impurity A
Sorafenib EP Impurity B
Sorafenib EP Impurity C
Sorafenib EP Impurity D
Sorafenib EP Impurity E
Sorafenib EP Impurity F
Sorafenib EP Impurity H
Sorafenib Impurity 1
Sorafenib Impurity 4
Sorafenib Impurity 5
Sorafenib N-Oxide
N-Desmethyl Sorafenib (Pyridine)-N-oxide
Sorafenib Hydroxydemethylamine
Sorafenib Impurity 3
Sorafenib Impurity 7
Sorafenib Impurity-II
4-Chloro-N-methylpyridine-2-carboxamide
N-Desmethyl Sorafenib
Sorafenib Tosylate
Sorafenib Related Compound 7
Sorafenib Carboxylic Acid Methyl Ester
Sorafenib Impurity 11
N-Methyl-4-phenoxypicolinamide
N-Methyl Picolinamide
